Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.

Published:1994 Issue:9 Volume:33 Page:517-524
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

TAKAHASHI Mitsuo¹,YUASA Ryoichi²,IMAI Terukuni³,TACHIBANA Hisao⁴,YORIFUJI Shiro⁵,NAKAMURA Yusaku¹,OGAWA Nobuya⁶

Affiliation:

1. The Department of Neurology, Kinki University School of Medicine

2. The Department of Neurology, Sakai Municipal Hospital

3. The Department of Neurology, Tazukekoufukai Kitano Hospital

4. The Fifth Department of Internal Medicine, Hyogo College of Medicine

5. The Department of Neurology, Osaka University School of Medicine

6. The Department of Pharmacology, Ehime University School of Medicine

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine1992/33/9/33_9_517/_pdf

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta‐analysis of randomized controlled trials;European Journal of Neurology;2022-12-11

2. Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis;Journal of Geriatric Psychiatry and Neurology;2021-12-29

3. Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis;European Journal of Clinical Pharmacology;2020-07-24

4. Selegiline: a molecule with innovative potential;Journal of Neural Transmission;2019-09-27

5. Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson’s disease: a meta-analysis;Aging Clinical and Experimental Research;2019-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3